Furthermore, manipulating certain transport processes in the tubules may impact glomerular pathology in DKD, as exemplified by how sodium-glucose cotransporter 2 (SGLT-2) blockers, which inhibit tubular reabsorption of glucose and sodium in the proximal tubule, improve GFR decline in DKD (12). This evidence concerns the gene SLC5A2 and diabetic kidney disease.